Not Signed In - Par Pharmaceutical Receives Approval For Ondansetron Orally Disintegrating Tablets
Fri, 29 Dec 2006 08:00 AM EST
... Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ondansetron orally disintegrating tablets (ODT) in 4 mg and 8 mg strengths. [click link for full article] ...
Related Topics
- Ondansetron
- Rizatriptan Disintegrating Tablets
- Clonazepam Orally Disintegrating Tablets
- Baclofen Disintegrating Tablets
- Clozapine Orally-Disentegrating Tablets
- Olanzapine Disintegrating Tablets
- Rizatriptan
- Carbinoxamine and Pseudoephedrine Tablets
- Lansoprazole Disintegrating Tablets
- Desloratadine Disintegrating Tablets
- Maxalt and Maxalt-MLT
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Haloperidol Tablets
- Thiabendazole Tablets
- Neostigmine Tablets
- Ondansetron Oral Solution
email this page
print this page
bookmark this page
feedback on this page
